Development of the site began in 2017 and following a successful inspection by the UK’s medicines regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA) in early 2019, the new facility is fully operational.
Investment in the state-of-the-art Clinical Services Centre of Excellence, which included £500,000 from the Welsh Government, means the company can offer an extended range of primary and secondary drug packaging, storage and distribution services from the site.
This milestone coincides with Sharp celebrating over thirty years in the delivery of clinical trial services in South Wales, which has secured over 70 skilled local jobs to the area with potential for more.
Ian Morgan, General Manager for Sharp Clinical Services UK, said:
“We are delighted to have officially ‘cut the ribbon’ on our brand-new clinical services facility in Rhymney. Investing in new facilities, increasing production capacity and expanding our capabilities helps us to meet growing demand for our services and is also an important way of creating jobs and supporting the communities where we operate.”
In designing the new facility, Sharp also demonstrated its commitment to the environment in which it operates, investing in a solar panel system which is already generating approximately 20% of its total annual electricity requirements.
“We have a long-standing history in the area and are dedicated to supporting both our customers and our employees for years to come and the investment in the Rhymney facility is a testament of that commitment.”
